Gabapentin Dosing Recommendations
Start gabapentin at 100-300 mg at bedtime or 100-300 mg three times daily, then increase by 100-300 mg every 1-7 days as tolerated, titrating up to a maximum of 3600 mg/day divided into three doses, with dose reductions required for renal impairment. 1, 2
Starting Dose
The FDA-approved initiation strategy depends on the indication 2:
- For postherpetic neuralgia: Begin with 300 mg on Day 1, increase to 600 mg/day (300 mg twice daily) on Day 2, then 900 mg/day (300 mg three times daily) on Day 3
- For epilepsy (adults ≥12 years): Start with 300 mg three times daily
- Alternative approach: 100-300 mg at bedtime or 100-300 mg three times daily, particularly useful for minimizing initial side effects 1
Titration Schedule
Increase by 100-300 mg every 1-7 days as tolerated 1. The guideline evidence emphasizes that gabapentin has nonlinear pharmacokinetics due to saturable absorption, requiring careful, gradual titration to optimize both efficacy and tolerability 1.
Target Maintenance Doses
- Minimum effective dose: 1800 mg/day (600 mg three times daily) 1, 2
- Standard maintenance range: 1800-3600 mg/day in three divided doses 1, 2
- Maximum dose: 3600 mg/day (1200 mg three times daily) 1, 2
The maximum time between doses should not exceed 12 hours 2. While doses up to 3600 mg/day have been well-tolerated, clinical studies show that additional benefit above 1800 mg/day was not consistently demonstrated, though some patients may require higher doses 1, 2.
Critical Dosing Considerations
Renal Impairment Adjustments (Essential)
Gabapentin requires mandatory dose reduction in renal dysfunction 1, 2. Use the following FDA-approved algorithm 2:
- CrCl ≥60 mL/min: 900-3600 mg/day (300-1200 mg three times daily)
- CrCl 30-59 mL/min: 400-1400 mg/day (200-700 mg twice daily)
- CrCl 15-29 mL/min: 200-700 mg/day (100-700 mg once daily)
- CrCl <15 mL/min: 100-300 mg/day (100-300 mg once daily)
- Hemodialysis patients: Maintenance dose based on CrCl plus supplemental post-dialysis dose of 125-350 mg after each 4-hour dialysis session
Geriatric Patients
Use lower starting doses and slower titration in elderly patients 1, 2. This population has decreased renal function (creatinine clearance declines from ~225 mL/min in those <30 years to ~125 mL/min in those >70 years), necessitating dose adjustment based on creatinine clearance 2.
Pediatric Dosing (Ages 3-11 years)
- Starting dose: 10-15 mg/kg/day in three divided doses 2
- Maintenance dose:
- Ages 3-4 years: 40 mg/kg/day in three divided doses
- Ages 5-11 years: 25-35 mg/kg/day in three divided doses
- Doses up to 50 mg/kg/day have been well-tolerated 2
Duration of Adequate Trial
Allow 3-8 weeks for titration plus 2 weeks at maximum tolerated dose before determining treatment failure 1. An adequate trial can require 2 months or more 1.
Common Pitfalls to Avoid
Failing to adjust for renal function: This is the most critical error, as gabapentin is renally excreted and accumulation leads to toxicity 1, 2
Titrating too rapidly: The nonlinear pharmacokinetics mean faster titration increases dose-dependent dizziness and sedation without improving efficacy 1
Stopping abruptly: Gabapentin must be tapered gradually over a minimum of 1 week when discontinuing to avoid withdrawal 2
Dosing more than three times daily or exceeding 12-hour intervals: This compromises efficacy due to saturable absorption 2
Expecting immediate pain relief: Unlike pregabalin, gabapentin requires longer titration periods to reach therapeutic effect 1